In his USFDA approved two multiple sclerosis durgs from Merck and Novartis: in his last days as the USFDA chief, Scott Gottlieb ray out a vision for replacing opioid.
The USFDA approved two multiple sclerosis drugs from Merck and Novartis. In his last days as the USFDA chief, Scott Gottlieb laid out a vision for replacing opioids.